Our use of transient or selective immunosuppression in generating HPV + tumor models also reflects the association of immunosuppressive conditions with increased susceptibility to HPV infection and cancer in clinically relevant scenarios, particularly in cases of HIV infection, which compromises CD4 T cells [79], and organ transplantation, which necessitates immunosuppressive therapy [80, 81]. Here, CD4 is linked to cancer.